Open AccessThe Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine
Author(s) -
Sivan Gazit,
Roei Shlezinger,
Galit Perez,
Roni Lotan,
Asaf Peretz,
Amir BenTov,
Esma Herzel,
Hillel Alapi,
Dani Cohen,
Khitam Muhsen,
Gabriel Chodick,
Tal Patalon
Publication year - 2022
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m21-4130
Subject(s) - medicine , hazard ratio , vaccination , randomized controlled trial , incidence (geometry) , cohort study , immunity , clinical trial , cohort , immunology , confidence interval , immune system , physics , optics
There is insufficient evidence regarding the magnitude and durability of protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 infection and vaccine-induced immunity.